Discriminative stimulus effects of nalbuphine in rhesus monkeys

LR Gerak and CP France

Department of Pharmacology, Louisiana State University Medical Center, New Orleans, USA.

Three rhesus monkeys discriminated between 0.178 mg/kg of nalbuphine and saline while responding under a fixed-ratio 5 schedule of stimulus- shock termination. Nalbuphine produced dose-related increases in drug- lever responding with > or = 90% of responses occurring on the drug lever at doses larger than 0.1 mg/kg. The duration of action of the discriminative stimulus effects of nalbuphine was less than 5.25 hr. Rank order potency of compounds that substituted for the nalbuphine discriminative stimulus (i.e., > or = 90% responding on the nalbuphine lever) in all three subjects was fentanyl > butorphanol > methadone > morphine. Compounds that did not substitute completely in all monkeys included the kappa agonists ethylketocyclazocine, enadoline, spiradoline and U-50,488 and the nonopioids cocaine, d-amphetamine, clonidine, ketamine and phencyclidine. Naltrexone antagonized the discriminative stimulus effects of nalbuphine, shifting the nalbuphine dose-effect curve in a manner that was consistent with mu receptor mediation. Results from the current study demonstrate that, in rhesus monkeys, the discriminative stimulus effects of nalbuphine are mediated by mu opioid receptors. Although there is evidence suggesting that nalbuphine has kappa agonist effects (e.g., subjective effects in humans), results from several studies, including the current study, strongly suggest that in rhesus monkeys nalbuphine does not exert agonist actions at kappa receptors. Moreover, these data indicate that differences in behavioral effects between nalbuphine and prototypic mu opioids (e.g., morphine) probably result from differences in activity (e.g., efficacy) at mu receptors rather than any kappa agonist actions of nalbuphine.

Volume 276, Issue 2, pp. 523-531, 02/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J.-X. Li, K. C. Rice, and C. P. France Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 827 - 833. [Abstract] [Full Text] [PDF]

				E. A. Walker, M. J. Picker, A. Granger, and L. A. Dykstra Effects of Opioids in Morphine-Treated Pigeons Trained to Discriminate among Morphine, the Low-Efficacy Agonist Nalbuphine, and Saline J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 150 - 158. [Abstract] [Full Text] [PDF]

				L. R. McMahon, S. L. Sell, and C. P. France Cocaine and Other Indirect-Acting Monoamine Agonists Differentially Attenuate a Naltrexone Discriminative Stimulus in Morphine-Treated Rhesus Monkeys J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 111 - 119. [Abstract] [Full Text] [PDF]

				G. J. Carey and J. Bergman Enadoline Discrimination in Squirrel Monkeys: Effects of Opioid Agonists and Antagonists J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 215 - 223. [Abstract] [Full Text]

				J. A. Vivian, M. B. DeYoung, T. L. Sumpter, J. R. Traynor, J. W. Lewis, and J. H. Woods kappa -Opioid Receptor Effects of Butorphanol in Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 259 - 265. [Abstract] [Full Text]

				M. R. Brandt and C. P. France Chronic l-Alpha Acetylmethadol in Rhesus Monkeys: Discriminative Stimulus and Other Behavioral Measures of Dependence and Withdrawal J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1029 - 1037. [Abstract] [Full Text]

				J. K. Rowlett, K. M. Wilcox, and W. L. Woolverton Self-Administration of Cocaine-Heroin Combinations by Rhesus Monkeys: Antagonism by Naltrexone J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 61 - 69. [Abstract] [Full Text]

				S. S. Negus, M. B. Gatch, and N. K. Mello Discriminative Stimulus Effects of a Cocaine/Heroin "Speedball" Combination in Rhesus Monkeys J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1123 - 1136. [Abstract] [Full Text]

				E. R. Butelman, M.-C. Ko, K. Sobczyk-Kojiro, H. I. Mosberg, B. V. Bemmel, G. Zernig, and J. H. Woods Kappa-Opioid Receptor Binding Populations in Rhesus Monkey Brain: Relationship to an Assay of Thermal Antinociception J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 595 - 601. [Abstract] [Full Text]

				M. R. Brandt, S. R. Cabansag, and C. P. France Discriminative Stimulus Effects of l-alpha -Acetylmethadol (LAAM), Buprenorphine and Methadone in Morphine-Treated Rhesus Monkeys J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 574 - 584. [Abstract] [Full Text]

				J. P. Zacny, K. Conley, and S. Marks Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Nalbuphine and Morphine in Healthy Volunteers J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1159 - 1169. [Abstract] [Full Text]